Willingness to pay for antenatal carrier screening for cystic fibrosis
Read Online
Share

Willingness to pay for antenatal carrier screening for cystic fibrosis

  • 774 Want to read
  • ·
  • 42 Currently reading

Published by Health Economics Research Unit, University of Aberdeen in Aberdeen .
Written in English


Book details:

Edition Notes

Statementby Cam Donaldson ... [et al.].
SeriesDiscussion paper / Health Economics Research Unit -- no.04/93
ContributionsDonaldson, Cam., University of Aberdeen. Health Economics Research Unit.
The Physical Object
Pagination[26]p. ;
Number of Pages26
ID Numbers
Open LibraryOL21428653M

Download Willingness to pay for antenatal carrier screening for cystic fibrosis

PDF EPUB FB2 MOBI RTF

Willingness to pay for antenatal carrier screening for cystic fibrosis (HERU discussion paper) on *FREE* shipping on qualifying offers. Willingness to pay for antenatal carrier screening for cystic fibrosis (HERU discussion paper) › Books › Health, Fitness & Dieting › Diseases & Physical Ailments. Several antenatal cystic fibrosis carrier screening trials have offered women testing by either the stepwise or the couple method. In this study, both approaches were described to women attending "Willingness-to-pay for road safety improvement," Post-Print halshs, HAL. Mouloud Haddak & Nathalie Havet & Marie Lefèvre, "Willingness-to-pay for road safety improvement," Working Papers , Groupe d'Analyse et de Théorie Economique Lyon St Stepwise or couple antenatal carrier screening for cystic fibrosis?: women'spreferences and willingness to pay Zosia Miedzybrodzka, June Semper, Phil Shackley, MonaAbdalla, CamDonaldson Abstract Several antenatal cystic fibrosis carrier screening trials have offered womentest-ing by either the stepwise or the couple method. In this study, both

  Objective: To estimate the cost effectiveness of different antenatal screening programmes for cystic fibrosis. Setting: Antenatal clinics and general practices in the United Kingdom. Design: Four components of the screening process were identified: information giving, DNA testing, genetic counselling, and prenatal diagnosis. The component costs were derived from the literature and from a RefWorks. American College of Obstetricians & Gynecologists PGD Cystic Fibrosis, MEDLINE, hu/En, L13, - June, Willingness to pay for antenatal carrier screening for cystic fibrosis. Source. Health Econ., , 4, 6, Prenatal cystic fibrosis carrier screening: factors in a woman's decision to decline testing. Source ?site= The aim of this paper is to provide an overview of the current scientific and economic thinking on the use of genetic technologies for cystic fibrosis (CF) screening. The paper takes a public health genetics viewpoint and gives an overview of the genetics behind CF, then describes current practices in screening for the disease. We then discuss the current literature on the economic evaluations (07)/references. A case study of willingness to pay for laparoscopic cholecystectomy.. Soc Sci Med, 44(5), Donaldson C, Shackley P & Abdalla M () Using willingness to pay to value close substitutes: carrier screening for cystic fibrosis revisited.. Health Econ, 6(2),

The aim of this paper is to provide an overview of the current scientific and economic thinking on the use of genetic technologies for cystic fibrosis (CF) screening. The paper takes a public health genetics viewpoint and gives an overview of the genetics behind CF, then describes current practices in screening for the disease. We then discuss the current literature on the economic evaluations (07)/abstract.   Several antenatal cystic fibrosis carrier screening trials have offered women testing by either the stepwise or the couple method. In this study, both approaches were described to women attending an antenatal clinic, who were then asked which method they preferred. An estimate of the value to women of each type of test was also ascertained using a "willingness to pay" (WTP) :// P. Shackley, J. Cairns / Health Policy 36 () Fig. 2. Decision tree for antenatal carrier screening for cystic fibrosis. outcome is assumed to be definitive information from the amniocentesis on the health status of the fetus, while the inferior outcome Willingness to pay for antenatal carrier screening for cystic fibrosis. By C. Donaldson, P. Shackley, M. Abdalla and Aberdeen Univ. (United Kingdom). Health Economics Research Unit. ://